Medicon Hellas S.A. Total Liabilities
Medicon Hellas S.A. total liabilities. Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) has total liabilities worth €14.85 Million EUR (≈ $17.37 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medicon Hellas S.A. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Medicon Hellas S.A. (2014–2022)
Total liabilities of Medicon Hellas S.A. from 2014 to 2022. This chart illustrates how Medicon Hellas S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore Medicon Hellas S.A. long-term investment intensity to see how much of total assets are deployed in long-term investments.
Medicon Hellas S.A. Competitors by Total Liabilities
The table below lists competitors of Medicon Hellas S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Venus Metals Corporation Ltd
AU:VMC
|
Australia | AU$353.13K |
|
Duoback Co. Ltd
KQ:073190
|
Korea | ₩17.87 Billion |
|
Volt Power Group Ltd
AU:VPR
|
Australia | AU$1.81 Million |
|
Lepidico Ltd
AU:LPD
|
Australia | AU$13.55 Million |
|
Spire Healthcare Group Plc
LSE:SPI
|
UK | GBX1.63 Billion |
|
Rocket One Inc.
NASDAQ:RKTO
|
USA | $1.43 Million |
|
Coral India Finance & Housing Limited
NSE:CORALFINAC
|
India | Rs159.58 Million |
|
Arzum Elektrikli Ev Aletleri Sanayi ve Ticaret AS
IS:ARZUM
|
Turkey | TL3.08 Billion |
Liability Composition Analysis (2014–2022)
This chart breaks down Medicon Hellas S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Medicon Hellas S.A. (MEDIC) total assets.
Liquidity & Leverage Metrics
Medicon Hellas S.A. Total Liabilities Ratios Explained
Medicon Hellas S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medicon Hellas S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medicon Hellas S.A. (2014–2022)
The table below shows the annual total liabilities of Medicon Hellas S.A. from 2014 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | €14.85 Million ≈ $17.37 Million |
-11.84% |
| 2021-12-31 | €16.85 Million ≈ $19.70 Million |
-4.17% |
| 2020-12-31 | €17.58 Million ≈ $20.56 Million |
-3.76% |
| 2019-12-31 | €18.27 Million ≈ $21.36 Million |
+4.20% |
| 2018-12-31 | €17.53 Million ≈ $20.50 Million |
-23.18% |
| 2017-12-31 | €22.82 Million ≈ $26.68 Million |
-15.15% |
| 2016-12-31 | €26.90 Million ≈ $31.45 Million |
+4.74% |
| 2015-12-31 | €25.68 Million ≈ $30.02 Million |
+2.22% |
| 2014-12-31 | €25.12 Million ≈ $29.37 Million |
-- |
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more